Skip to main content
logo
Medicenna Therapeutics Corp. (TSX:MDNA)
Canada flag Canada · Delayed Price · Currency is CAD
0.4400
-0.0100 (-2.22%)
Oct 19, 2026, 10:24 AM EST

Medicenna Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
4153771306192
Market Cap Growth
-45.90%-30.35%-40.82%111.36%-33.17%-66.08%
Enterprise Value
3543471082568
Last Close Price
0.450.640.981.860.881.65

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
24.8321.514.0124.952.084.40
P/TBV Ratio
25.5121.934.0325.232.084.42

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.060.050.01---
Net Debt / Equity Ratio
-3.34-2.47-1.29-3.27-1.14-0.99
Net Debt / EBITDA Ratio
0.250.271.210.912.060.92
Net Debt / FCF Ratio
0.300.341.491.042.650.87
Quick Ratio
1.111.396.216.344.958.33
Current Ratio
1.251.526.356.665.238.92
Return on Equity (ROE)
-227.57%-170.63%-97.22%-146.88%-39.94%-76.56%
Return on Assets (ROA)
-90.10%-76.07%-53.68%-42.00%-34.02%-42.75%
Return on Capital Employed (ROCE)
-1271.10%-750.00%-85.20%-114.80%-55.30%-107.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-44.69%-34.48%-15.40%-19.66%-16.40%-24.62%
FCF Yield
-45.28%-33.57%-21.56%-12.55%-20.65%-25.72%
Buyback Yield / Dilution
-6.75%-8.51%-10.10%-7.57%-19.25%-9.31%